cbdMD (YCBD) Profit After Tax (2016 - 2025)
cbdMD (YCBD) reported Profit After Tax of -$283131.0 for Q4 2025, down 1975.66% on a YoY basis from $15095.0 in Q4 2024, and up 58.36% sequentially from -$679968.0 in Q3 2025.
cbdMD (YCBD) Profit After Tax (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Profit After Tax data on file, last reported at -$283131.0 in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 1975.66% year-over-year to -$283131.0; the trailing twelve-month figure through Dec 2025 stood at -$2.3 million (up 13.0% YoY), and the FY2025 full-year result was -$2.0 million, up 44.84% from the prior year.
- Profit After Tax rose to -$283131.0 in Q4 2025, from -$679968.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $1.5 million in Q2 2021 to a low of -$31.6 million in Q2 2022.
- A 5-year average of -$5.7 million and a median of -$1.6 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 2157.79% in 2022 and soared 125.97% in 2024, its largest moves.
- Tracing YCBD's Profit After Tax over 5 years: stood at -$19.2 million in 2021, then surged by 79.35% to -$4.0 million in 2022, then surged by 74.81% to -$996501.0 in 2023, then soared by 101.51% to $15095.0 in 2024, then tumbled by 1975.66% to -$283131.0 in 2025.
- Business Quant data shows YCBD's Profit After Tax at -$283131.0 in Q4 2025, -$679968.0 in Q3 2025, and -$895272.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | -283,131.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -283,131.00 |
| Sep 30, 2025 | -679,968.00 |
| Jun 30, 2025 | -895,272.00 |
| Mar 31, 2025 | -480,757.00 |
| Dec 31, 2024 | 15,095.00 |
| Sep 30, 2024 | -152,798.00 |
| Jun 30, 2024 | 459,737.00 |
| Mar 31, 2024 | -3.01 Mn |
| Dec 31, 2023 | -996,501.00 |
| Sep 30, 2023 | -15.87 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | -1.34 Mn |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -14.63 Mn |
| Jun 30, 2022 | -31.63 Mn |
| Mar 31, 2022 | -4.66 Mn |
| Dec 31, 2021 | -19.16 Mn |
| Sep 30, 2021 | -3.03 Mn |
| Jun 30, 2021 | 1.54 Mn |
| Mar 31, 2021 | -12.51 Mn |